Clearmind Medicine Inc.

The momentum for this stock is not very good. Clearmind Medicine Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Clearmind Medicine Inc..
Log in to see more information.
CMND Fundamental Data by TradingView

News

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Globe Newswire Innovative compounds designed to address critical unmet needs in PTSD treatment Vancouver, Canada, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0...\n more…

SciSparc and Clearmind Innovate Mental Health Treatment
SciSparc and Clearmind Innovate Mental Health Treatment

TipRanks Financial Blog SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., in collaboration with Clearmind Medicine Inc., has announced the publication of an international patent ...\n more…

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Globe Newswire Pioneering Therapeutic Approach Aims to Enhance Safety and Efficacy in Mental Health and Addiction Treatments TEL AVIV, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC...\n more…

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Globe Newswire Pioneering Therapeutic Approach Aims to Enhance Safety and Efficacyin Mental Health and Addiction Treatments Vancouver, Canada, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq...\n more…

SciSparc, Clearmind Medicine deal leads to publication of ketamine combo
SciSparc, Clearmind Medicine deal leads to publication of ketamine combo

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

Globe Newswire TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...\n more…